View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
April 26, 2019

UK researcher to use computational method to develop new medical devices

University of Leeds researcher Alejandro Frangi has received funding support from the Royal Academy of Engineering to develop a new approach to discover, develop and test new medical devices.

University of Leeds researcher Alejandro Frangi has received funding support from the Royal Academy of Engineering to develop a new approach to discover, develop and test new medical devices based on computational ‘in-silico’ trials.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

During the in-silico approach, computer analysis will be leveraged to create medical devices from their conception and ensure optimum clinical outcomes through designs targeting a variety of patient groups.

This method is expected to offer an alternative to other innovation processes, which can sometimes result in medical technologies which do not work for all patients. This can require suspension of development, leading to high costs.

In in-silico testing, computer simulations will analyse how and when a device could fail, cause harm or become ineffective in certain populations.

“Computational medicine can bring about a complete shift in the way devices are conceived, developed, and ultimately tested for the market.”

The trials will involve virtual patient populations, dubbed virtual patient chimeras, representing the natural anatomical, physiological and biological variations present in real-life people.

Frangi said: “It is a huge waste of money with product development teams having to go back to the drawing board or even scrap a project.

“Similar problems exist in drug development with less than 10% of the drugs in various phases of clinical trials eventually ending up being marketed, either because they are proven to be ineffective or unsafe.”

Data from patient and tissue databases will be used to build these virtual chimeras.

As the technique is carried out long before in-human testing, it is expected to cause minimal harm to both animals and humans, compared with the existing process.

While the in-silico trials do not eliminate the need for real-life patient studies, they are expected to help identify and resolve any challenges before the device advances into clinical development.

Frangi added: “Computational medicine can bring about a complete shift in the way devices are conceived, developed, and ultimately tested for the market.”

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network